HALO Raises 2025 Financial Guidance, Keeps 2024 View, Stock Up
Shares of Halozyme Therapeutics, Inc. HALO were up 5% on Jan. 8 after the company raised its guidance for 2025. The stock gained another 1.8% in after-hours trading. HALO also maintained its full-year 2024 financial guidance The company also announced that it has entered into a new $250 million accelerated share repurchase program under the previously announced $750 million share repurchase program.